Nirman Agri Genetics Share Price Today | Stock Price & Nirman Agri Genetics Share Screener
Track the current Nirman Agri Genetics share price and stock price live with TickJournal's free stock screener. Check Nirman Agri Genetics yearly highs lows for the annual price range and momentum. Use the Nirman Agri Genetics stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Nirman Agri Genetics opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹237 and net income of ₹25, with EBITDA of ₹27, an operating margin of 11.0% and a profit margin of 10.6%.
Nirman Agri Genetics Share Price Chart
Track the current stock price of Nirman Agri Genetics with an interactive chart. Analyse NIRMAN share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Nirman Agri Genetics stock quote in one place.
Nirman Agri Genetics Company Profile - Fundamental Screener
Screen Nirman Agri Genetics company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for NIRMAN shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the FMCG sector and the Agricultural Products industry, and it trades under ISIN INE0OK701014.
Company Details
Classification
Identifiers and Leadership
Nirman Agri Genetics Balance Sheet Screener
Screen NIRMAN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹129, up from ₹113 in 2025.
Latest statistics put total assets at ₹129 and shareholder funds at ₹128.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
Assets |
||||||
| Total Assets | 129 | 113 | 44 | 30 | 6 | 2 |
| Current Assets | 118 | 101 | 22 | 9 | 6 | 2 |
| Fixed Assets | 2 | 2 | 0 | 1 | 0 | 0 |
Liabilities |
||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 0 | 0 | 0 | 1 | 1 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||
| Total Equity | 128 | 110 | 37 | 27 | 3 | 0 |
| Share Capital | 8 | 8 | 6 | 6 | 0 | 0 |
| Reserves & Surplus | 120 | 102 | 31 | 21 | 3 | 0 |
Nirman Agri Genetics Income Statement Screener - Profit & Revenue Analysis
Screen Nirman Agri Genetics income statement and profit fundamentals. Analyze NIRMAN quarterly results. Nirman Agri Genetics reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹237 and net profit was ₹25, equal to earnings per unit of ₹33.50, at an operating margin of 11%.
In that period expenses were ₹210, interest cost ₹0 and tax ₹1. The next period listed, 2026-March, shows revenue of ₹197 and net profit of ₹18.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March |
|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||
| Revenue | 237 | 197 | 237 | 63 | 29 | 14 | 4 |
| Expenses | 210 | 178 | 210 | 52 | 24 | 10 | 4 |
Operating Costs and Margins | |||||||
| EBITDA | 27 | 19 | 27 | 11 | 4 | 3 | 0 |
| Operating Profit % | 11.00% | 10.00% | 11.00% | 18.00% | 15.00% | 25.00% | 2.00% |
| Depreciation | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit and Earnings | |||||||
| Profit Before Tax | 26 | 18 | 26 | 11 | 4 | 3 | 0 |
| Tax | 1 | 1 | 1 | 1 | 0 | 1 | 0 |
| Net Profit | 25 | 18 | 25 | 10 | 4 | 3 | 0 |
| EPS | 33.50 | 21.98 | 31.57 | 12.99 | 10.24 | 2560.20 | 54.70 |
Nirman Agri Genetics Cash Flow Screener - Liquidity Fundamentals
Screen NIRMAN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities used ₹25, and net cash flow was an outflow of ₹25.
Over the same period, investing activities provided ₹0 and financing activities used ₹1.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March |
|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||
| Operating Activities | -25 | -32 | 4 | 0 | 0 | 0 |
| Investing Activities | 0 | 10 | -2 | -21 | 0 | 0 |
Financing and Net Cash | ||||||
| Financing Activities | -1 | 46 | -1 | 20 | 0 | 1 |
| Net Cash Flow | -25 | 24 | 1 | -1 | 0 | 1 |
Nirman Agri Genetics Shareholding Pattern Screener
See Nirman Agri Genetics shareholding pattern with promoter, FII, and DII holdings. Check Nirman Agri Genetics promoter holding and ownership changes for NIRMAN on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 44.34%, foreign institutions 0.02%, domestic institutions 0.00% and the public 52.27%, spread across 4,212 shareholders.
The shareholder count was 4,212 in 2026-Mar, compared with 2,895 in 2025-Mar.
| Item | 2026-Mar | 2025-Mar | 2025-Sept | 2024-Mar | 2024-Sept | 2023-Mar | 2023-Sept | 2023-Dec |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 44.34% | 57.96% | 44.34% | 66.05% | 57.81% | 65.59% | 66.05% | 66.05% |
Institutional Investors | ||||||||
| FII Holding | 0.02% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 52.27% | 38.47% | 49.88% | 30.38% | 37.75% | 25.86% | 23.42% | 24.58% |
| Other Holding | 3.38% | 3.57% | 5.78% | 3.57% | 4.45% | 8.56% | 10.53% | 9.37% |
| Shareholder Count | 4,212 | 2,895 | 4,017 | 1,281 | 2,231 | 7 | 639 | 752 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Nirman Agri Genetics. Nirman Agri Genetics dividend yield can be compared with peers and other stocks in the market.
Nirman Agri Genetics Stock Index Membership - Nifty & Sensex
See which indices include Nirman Agri Genetics stock. Check NIRMAN index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Nirman Agri Genetics Market Events Screener - Corporate Actions
Get Nirman Agri Genetics corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Nirman Agri Genetics stock events that may affect NIRMAN share price, along with derivatives, futures and options activity and sector gainers.
8 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated May 30, 2026, with a record date of May 30, 2026.
It is followed by Quarterly Result Announcement dated November 14, 2025 and Quarterly Result Announcement dated May 30, 2025.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-30 | 2026-05-30 | Quarterly Result Announcement | NA | -2.98% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -18.45% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 2.41% |
| 2025-02-05 | 2025-02-05 | Quarterly Result Announcement | NA | 1.29% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | 2.64% |
| 2024-09-30 | 2024-09-30 | Annual General Meeting | NA | -0.61% |
| 2024-09-25 | 2024-09-25 | Dividend | ₹ 2.00 /share | -12.68% |
| 2024-07-29 | 2024-07-29 | Rights | 11:32 | -1.62% |
Nirman Agri Genetics Competitors Screener - Peer Stocks Comparison
Screen NIRMAN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the FMCG sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| LT Foods | 14,046 | 21.85 | 11,023 | 25.69% | 625 | 36.68 |
| KRBL | 8,879 | 11.69 | 6,168 | 9.07% | 648 | 41.32 |
| Gujarat Ambuja Exports | 7,415 | 17.83 | 5,836 | 24.30% | 304 | 46.79 |
| Trualt Bioenergy | 3,939 | 24.67 | 1,814 | -7.85% | 97 | 62.70 |
| Kaveri Seed Company | 3,781 | 15.39 | 1,424 | 13.81% | 296 | 48.84 |
| Sanstar | 2,128 | 61.63 | 785 | -27.46% | 35 | 39.44 |
| Amir Chand Jagdish Kumar (Exports) | 2,121 | 16.88 | 2,287 | 14.13% | 103 | 56.22 |
| GRM Overseas | 1,642 | 21.35 | 1,806 | 31.41% | 76 | 33.72 |
| Chaman Lal Setia Exports | 1,424 | 11.27 | 1,450 | -3.56% | 115 | 40.96 |
| Avt Natural Products | 1,382 | 16.77 | 727 | 27.04% | 65 | 55.81 |
Nirman Agri Genetics Company Announcements - News & Reports Screener
Screen NIRMAN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
Frequently Asked Questions
How is the company valued right now?
The P/E ratio is 1.21 and the P/B ratio is 0.17, with earnings per unit of ₹21.98. Market capitalisation stands at ₹21.59 Cr. The company operates in the FMCG sector, in the Agricultural Products industry, so compare these ratios with its sector peers in the table above.
About This Data
Key statistics were last updated on October 6, 2026. This page covers 6 balance sheet periods, 7 income statement periods, 6 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.